CPT1A Supports Castration-Resistant Prostate Cancer in Androgen-Deprived Conditions

Prostate cancer (PCa) is the most common cancer in men, and the global burden of the disease is rising. The majority of PCa deaths are due to metastasis that are highly resistant to current hormonal treatments; this state is called castration-resistant prostate cancer (CRPC). In this study, we focus...

Descripción completa

Detalles Bibliográficos
Autores principales: Joshi, Molishree, Stoykova, Gergana E., Salzmann-Sullivan, Maren, Dzieciatkowska, Monika, Liebman, Lauren N., Deep, Gagan, Schlaepfer, Isabel R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830347/
https://www.ncbi.nlm.nih.gov/pubmed/31547059
http://dx.doi.org/10.3390/cells8101115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830347/
https://www.ncbi.nlm.nih.gov/pubmed/31547059
http://dx.doi.org/10.3390/cells8101115

Ejemplares similares